Now showing items 1-5 of 5
Sample preference for colorectal cancer screening tests: blood or stool?
(Scientific Research Publishing, 2012-08)
Objective: Despite the high prevalence of CRC and the proven benefits of faecal sampling tests, participation rates in CRC screening are suboptimal. Literature has identified a number of barriers to participation, including ...
Using the Transtheoretical Model of Behaviour Change to describe readiness to rescreen for colorectal cancer with Faecal Occult Blood Testing
(CSIRO Publishing, 2012)
Issue addressed: This study used the Transtheoretical Model of Behaviour Change (TTM) to describe reparticipation in colorectal cancer (CRC) screening according to social cognitive and background variables. Methods: A ...
Predictors of re-participation in faecal occult blood test-based screening for colorectal cancer
(National Cancer Center, Korea, 2012)
Background: There is little information on longitudinal patterns of participation in faecal occult blood test (FOBT) based colorectal cancer (CRC) screening or on demographic or behavioural factors associated with participation ...
Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing
(Public Library of Science, 2012-01-19)
Results: Genome-wide analysis uncovered reproducible gene expression signatures for both adenomas and cancers compared to controls. 386/489 (79%) of the adenoma and 439/529 (83%) of the adenocarcinoma biomarkers were ...
Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia
Objective: To synthesize cost and health outcomes for current treatment pathways for esophageal adenocarcinoma and high grade dysplasia, and model comparative net clinical and economic benefits of alternative management ...